Advanced Solid Tumors: IDE397 Treatment Study

We are evaluating a new drug, IDE397, for adults with advanced solid tumors to see how safe it is and how the body responds to it. This study aims to gather important information about its effects on cancer.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Institut Bergonié
Oncologie Médicale
Bordeaux, France
Centre Hospitalier Regional De Marseille
CEPCM
Marseille, France
Centre Hospitalier Universitaire De Toulouse
Oncologie Médicale
Portet-sur-Garonne, France

Sponsor: Ideaya Biosciences Inc.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.